The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

To meet demand, India’s label industry is adopting digital printing for quick, on-demand responses and prioritizing ...

I'm a registered dietitian and my husband is a personal trainer, and we loved shopping for products to help us meet our goals ...

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Looking for Round Rock electricity providers? Use our guide to compare Round Rock electricity rates and plans to save on ...

Both butters affected listed cream as an ingredient but didn't contain an allergen disclaimer regarding milk, the FDA said.

Dr. Ajay Bakhshi, MD, a gastrointestinologist based in Maryland, points out that an IBS diagnosis is typically given when a ...

The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...

Fast forward to Taylor’s very first runway show after launching her namesake contemporary label in 2012, and she even sent ...

Spirovant has announced the commencement of its Phase I/II study with the first patient receiving a dose of SP-101 to treat ...

GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...

So you've decided to move your existing email to a secure email option? Great, now here's what you need to do.